Paul Ince - Publications

Affiliations: 
Neuropathology University of Sheffield, Sheffield, England, United Kingdom 

57 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Wharton SB, Simpson JE, Ince PG, Richardson CD, Merrick R, Matthews FE, Brayne C. Insights into the pathological basis of dementia from population-based neuropathology studies. Neuropathology and Applied Neurobiology. 49: e12923. PMID 37462105 DOI: 10.1111/nan.12923  0.389
2023 Rajab MD, Jammeh E, Taketa T, Brayne C, Matthews FE, Su L, Ince PG, Wharton SB, Wang D. Assessment of Alzheimer-related pathologies of dementia using machine learning feature selection. Alzheimer's Research & Therapy. 15: 47. PMID 36895019 DOI: 10.1186/s13195-023-01195-9  0.318
2021 Ellmerich S, Taylor GW, Richardson CD, Minett T, Schmidt AF, Brayne C, Matthews FE, Ince PG, Wharton SB, Pepys MB. Dementia in the older population is associated with neocortex content of serum amyloid P component. Brain Communications. 3: fcab225. PMID 34671726 DOI: 10.1093/braincomms/fcab225  0.344
2020 Chambers A, Bury JJ, Minett T, Richardson CD, Brayne C, Ince PG, Shaw PJ, Garwood CJ, Heath PR, Simpson JE, Matthews FE, Wharton SB. Advanced Glycation End Product Formation in Human Cerebral Cortex Increases With Alzheimer-Type Neuropathologic Changes but Is Not Independently Associated With Dementia in a Population-Derived Aging Brain Cohort. Journal of Neuropathology and Experimental Neurology. PMID 32766675 DOI: 10.1093/Jnen/Nlaa064  0.431
2019 Wharton SB, Wang D, Parikh C, Matthews FE, Brayne C, Ince PG. Epidemiological pathology of Aβ deposition in the ageing brain in CFAS: addition of multiple Aβ-derived measures does not improve dementia assessment using logistic regression and machine learning approaches. Acta Neuropathologica Communications. 7: 198. PMID 31806014 DOI: 10.1186/S40478-019-0858-4  0.442
2019 Hase Y, Polvikoski TM, Firbank MJ, Craggs LJ, Hawthorne E, Platten C, Stevenson W, Deramecourt V, Ballard C, Kenny RA, Perry RH, Ince P, Carare RO, Allan LM, Horsburgh K, et al. Small Vessel Disease Pathological Changes in Neurodegenerative and Vascular Dementias concomitant with Autonomic Dysfunction. Brain Pathology (Zurich, Switzerland). PMID 31357238 DOI: 10.1111/Bpa.12769  0.466
2018 Simpson JE, Wharton S, Brayne C, Matthews F, Heath P, Ince P. S5-01-01: Ageing And Neuroimmunology: White Matter Pathology Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2964  0.303
2018 Ajikumar A, Ridger V, Heath P, Wharton S, Ince P, Simpson JE. P4-059: Neutrophil-Derived Microvesicle-Induced Blood Brain Barrier Dysfunction: A Potential Mechanism Linking Systemic Inflammation And Dementia Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2462  0.315
2016 McAleese KE, Alafuzoff I, Charidimou A, De Reuck J, Grinberg LT, Hainsworth AH, Hortobagyi T, Ince P, Jellinger K, Gao J, Kalaria RN, Kovacs GG, Kövari E, Love S, Popovic M, et al. Post-mortem assessment in vascular dementia: advances and aspirations. Bmc Medicine. 14: 129. PMID 27600683 DOI: 10.1186/S12916-016-0676-5  0.392
2016 Taga M, Minett T, Classey J, Matthews FE, Brayne C, Ince PG, Nicoll JA, Hugon J, Boche D. Metaflammasome components in the human brain: a role in dementia with alzheimer's pathology? Brain Pathology (Zurich, Switzerland). PMID 27106634 DOI: 10.1111/bpa.12388  0.315
2016 Wharton SB, Minett T, Drew D, Forster G, Matthews F, Brayne C, Ince PG. Epidemiological pathology of Tau in the ageing brain: application of staging for neuropil threads (BrainNet Europe protocol) to the MRC cognitive function and ageing brain study. Acta Neuropathologica Communications. 4: 11. PMID 26857919 DOI: 10.1186/s40478-016-0275-x  0.316
2015 Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H, Cairns NJ, Crary JF, Duyckaerts C, Ghetti B, Halliday GM, Ironside JW, Love S, Mackenzie IR, Munoz DG, ... ... Ince P, et al. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathologica. PMID 26659578 DOI: 10.1007/S00401-015-1509-X  0.392
2015 Simpson JE, Ince PG, Matthews FE, Shaw PJ, Heath PR, Brayne C, Garwood C, Higginbottom A, Wharton SB. A neuronal DNA damage response is detected at the earliest stages of Alzheimer's neuropathology and correlates with cognitive impairment in the Medical Research Council's Cognitive Function and Ageing Study ageing brain cohort. Neuropathology and Applied Neurobiology. 41: 483-96. PMID 25443110 DOI: 10.1111/Nan.12202  0.317
2014 Garwood CJ, Simpson JE, Al Mashhadi S, Axe C, Wilson S, Heath PR, Shaw PJ, Matthews FE, Brayne C, Ince PG, Wharton SB. DNA damage response and senescence in endothelial cells of human cerebral cortex and relation to Alzheimer's neuropathology progression: a population-based study in the Medical Research Council Cognitive Function and Ageing Study (MRC-CFAS) cohort. Neuropathology and Applied Neurobiology. 40: 802-14. PMID 24861546 DOI: 10.1111/nan.12156  0.316
2013 Cooper-Knock J, Highley JR, Hartley J, Milano A, Sawcer S, Compston A, Frolov A, Charlesworth G, Wood N, Bandmann O, McDermott CJ, Kirby J, Ince P, Shaw P. Neurodegeneration caused by intronic expansions of C9ORF72 is a clinically heterogeneous but pathologically distinct disease The Lancet. 381. DOI: 10.1016/S0140-6736(13)60472-9  0.354
2012 Deramecourt V, Slade JY, Oakley AE, Perry RH, Ince PG, Maurage CA, Kalaria RN. Staging and natural history of cerebrovascular pathology in dementia. Neurology. 78: 1043-50. PMID 22377814 DOI: 10.1212/Wnl.0B013E31824E8E7F  0.368
2012 Cooper-Knock J, Hewitt C, Highley JR, Brockington A, Milano A, Man S, Martindale J, Hartley J, Walsh T, Gelsthorpe C, Baxter L, Forster G, Fox M, Bury J, Mok K, ... ... Ince PG, et al. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain : a Journal of Neurology. 135: 751-64. PMID 22366792 DOI: 10.1093/Brain/Awr365  0.356
2012 Stephan BC, Matthews FE, Ma B, Muniz G, Hunter S, Davis D, McKeith IG, Foster G, Ince PG, Brayne C. Alzheimer and vascular neuropathological changes associated with different cognitive States in a non-demented sample. Journal of Alzheimer's Disease : Jad. 29: 309-18. PMID 22233761 DOI: 10.3233/Jad-2011-110518  0.327
2012 Valenzuela MJ, Matthews FE, Brayne C, Ince P, Halliday G, Kril JJ, Dalton MA, Richardson K, Forster G, Sachdev PS. Multiple biological pathways link cognitive lifestyle to protection from dementia. Biological Psychiatry. 71: 783-91. PMID 22055015 DOI: 10.1016/J.Biopsych.2011.07.036  0.428
2012 Keage HA, Ince PG, Matthews FE, Wharton SB, McKeith IG, Brayne C. Impact of less common and "disregarded" neurodegenerative pathologies on dementia burden in a population-based cohort. Journal of Alzheimer's Disease : Jad. 28: 485-93. PMID 22045491 DOI: 10.3233/Jad-2011-111268  0.337
2012 Stephan BC, Matthews FE, Hunter S, Savva GM, Bond J, McKeith IG, Ince P, Brayne C. Neuropathological profile of mild cognitive impairment from a population perspective. Alzheimer Disease and Associated Disorders. 26: 205-12. PMID 21946014 DOI: 10.1097/Wad.0B013E31822Fc24D  0.461
2012 Stephan BC, Wharton SB, Simpson J, Matthews FE, Ince P, Brayne C. The epidemiological neuropathology of dementia and the implications for drug development Neurodegenerative Disease Management. 2: 471-482. DOI: 10.2217/Nmt.12.51  0.454
2011 Viggars AP, Wharton SB, Simpson JE, Matthews FE, Brayne C, Savva GM, Garwood C, Drew D, Shaw PJ, Ince PG. Alterations in the blood brain barrier in ageing cerebral cortex in relationship to Alzheimer-type pathology: a study in the MRC-CFAS population neuropathology cohort. Neuroscience Letters. 505: 25-30. PMID 21970975 DOI: 10.1016/J.Neulet.2011.09.049  0.314
2011 Simpson JE, Ince PG, Shaw PJ, Heath PR, Raman R, Garwood CJ, Gelsthorpe C, Baxter L, Forster G, Matthews FE, Brayne C, Wharton SB. Microarray analysis of the astrocyte transcriptome in the aging brain: relationship to Alzheimer's pathology and APOE genotype. Neurobiology of Aging. 32: 1795-807. PMID 21705112 DOI: 10.1016/J.Jalz.2011.05.1596  0.396
2011 Wharton SB, Brayne C, Savva GM, Matthews FE, Forster G, Simpson J, Lace G, Ince PG. Epidemiological neuropathology: the MRC Cognitive Function and Aging Study experience. Journal of Alzheimer's Disease : Jad. 25: 359-72. PMID 21422529 DOI: 10.3233/JAD-2011-091402  0.383
2011 Tsopelas C, Stewart R, Savva GM, Brayne C, Ince P, Thomas A, Matthews FE. Neuropathological correlates of late-life depression in older people. The British Journal of Psychiatry : the Journal of Mental Science. 198: 109-14. PMID 21282780 DOI: 10.1192/Bjp.Bp.110.078816  0.391
2011 Nicoll JA, Savva GM, Stewart J, Matthews FE, Brayne C, Ince P. Association between APOE genotype, neuropathology and dementia in the older population of England and Wales. Neuropathology and Applied Neurobiology. 37: 285-94. PMID 20880354 DOI: 10.1111/J.1365-2990.2010.01130.X  0.435
2011 Love S, Chalmers K, Esiri M, Ince P, Kehoe P. Validation of an internationally developed protocol to assess the distribution and severity of cerebral amyloid angiopathy in the post-mortem brain Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.09.170  0.305
2011 Keage H, Ince P, Matthews F, Wharton S, McKieth I, Brayne C. Less common and “disregarded” pathologies in late onset dementia: what are we missing? Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1724  0.416
2009 Matthews FE, Brayne C, Lowe J, McKeith I, Wharton SB, Ince P. Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study. Plos Medicine. 6: e1000180. PMID 19901977 DOI: 10.1371/Journal.Pmed.1000180  0.421
2009 Strong MJ, Grace GM, Freedman M, Lomen-Hoerth C, Woolley S, Goldstein LH, Murphy J, Shoesmith C, Rosenfeld J, Leigh PN, Bruijn L, Ince P, Figlewicz D. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 10: 131-46. PMID 19462523 DOI: 10.1080/17482960802654364  0.371
2009 Wharton SB, O'Callaghan JP, Savva GM, Nicoll JA, Matthews F, Simpson JE, Forster G, Shaw PJ, Brayne C, Ince PG. Population variation in glial fibrillary acidic protein levels in brain ageing: relationship to Alzheimer-type pathology and dementia. Dementia and Geriatric Cognitive Disorders. 27: 465-73. PMID 19420941 DOI: 10.1159/000217729  0.334
2008 Alafuzoff I, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Braak H, Bugiani O, Del-Tredici K, Ferrer I, Gelpi E, Giaccone G, Graeber MB, Ince P, Kamphorst W, King A, et al. Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium. Brain Pathology (Zurich, Switzerland). 18: 484-96. PMID 18371174 DOI: 10.1111/J.1750-3639.2008.00147.X  0.388
2008 Zaccai J, Brayne C, McKeith I, Matthews F, Ince PG. Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort. Neurology. 70: 1042-8. PMID 18362284 DOI: 10.1212/01.Wnl.0000306697.48738.B6  0.346
2006 Thomas AJ, Hendriksen M, Piggott M, Ferrier IN, Perry E, Ince P, O'Brien JT. A study of the serotonin transporter in the prefrontal cortex in late-life depression and Alzheimer's disease with and without depression. Neuropathology and Applied Neurobiology. 32: 296-303. PMID 16640648 DOI: 10.1111/J.1365-2990.2006.00728.X  0.318
2006 Zaccai J, Brayne C, Ince P. P4-155: Alpha-synucleinopathy in a multicenter population-based elderly cohort-MRC cognitive function and ageing study: Associations with in-life cognitive data Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.1894  0.332
2004 Kalaria RN, Kenny RA, Ballard CG, Perry R, Ince P, Polvikoski T. Towards defining the neuropathological substrates of vascular dementia. Journal of the Neurological Sciences. 226: 75-80. PMID 15537525 DOI: 10.1016/J.Jns.2004.09.019  0.348
2004 Hendricksen M, Thomas AJ, Ferrier IN, Ince P, O'Brien JT. Neuropathological study of the dorsal raphe nuclei in late-life depression and Alzheimer's disease with and without depression. The American Journal of Psychiatry. 161: 1096-102. PMID 15169699 DOI: 10.1176/Appi.Ajp.161.6.1096  0.319
2003 Kalaria RN, Thomas A, Oakley A, Ince P, Tamaoka A, Mori H, Kenny RA, Ballard C. Cerebrovascular Amyloidosis and Dementia Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents. 3: 317-327. DOI: 10.2174/1568013033483267  0.428
2001 Ince P. Dementia with Lewy bodies. Advances in Experimental Medicine and Biology. 487: 135-45. PMID 11403155 DOI: 10.1007/978-1-4615-1249-3_12  0.412
2001 Kalaria RN, Ballard CG, Ince PG, Kenny RA, McKeith IG, Morris CM, O'Brien JT, Perry EK, Perry RH, Edwardson JA. Multiple substrates of late-onset dementia: implications for brain protection. Novartis Foundation Symposium. 235: 49-60; discussion 60. PMID 11280033  0.416
2000 Ballard C, O'Brien J, Swann A, Neill D, Lantos P, Holmes C, Burn D, Ince P, Perry R, McKeith I. One year follow-up of parkinsonism in dementia with Lewy bodies. Dementia and Geriatric Cognitive Disorders. 11: 219-22. PMID 10867448 DOI: 10.1159/000017240  0.314
2000 McKeith IG, Ballard CG, Perry RH, Ince PG, O'Brien JT, Neill D, Lowery K, Jaros E, Barber R, Thompson P, Swann A, Fairbairn AF, Perry EK. Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology. 54: 1050-8. PMID 10720273 DOI: 10.1212/Wnl.54.5.1050  0.3
2000 Ballard C, McKeith I, O'Brien J, Kalaria R, Jaros E, Ince P, Perry R. Neuropathological substrates of dementia and depression in vascular dementia, with a particular focus on cases with small infarct volumes. Dementia and Geriatric Cognitive Disorders. 11: 59-65. PMID 10705161 DOI: 10.1159/000017215  0.369
1999 Ballard C, Holmes C, McKeith I, Neill D, O'Brien J, Cairns N, Lantos P, Perry E, Ince P, Perry R. Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease. The American Journal of Psychiatry. 156: 1039-45. PMID 10401449 DOI: 10.1176/Ajp.156.7.1039  0.425
1999 Barber R, Scheltens P, Gholkar A, Ballard C, McKeith I, Ince P, Perry R, O'Brien J. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. Journal of Neurology, Neurosurgery, and Psychiatry. 67: 66-72. PMID 10369824 DOI: 10.1136/Jnnp.67.1.66  0.38
1999 Ballard CG, Ayre G, O'Brien J, Sahgal A, McKeith IG, Ince PG, Perry RH. Simple standardised neuropsychological assessments aid in the differential diagnosis of dementia with Lewy bodies from Alzheimer's disease and vascular dementia. Dementia and Geriatric Cognitive Disorders. 10: 104-8. PMID 10026383 DOI: 10.1159/000017109  0.31
1998 Ballard CG, O'Brien J, Lowery K, Ayre GA, Harrison R, Perry R, Ince P, Neill D, McKeith IG. A prospective study of dementia with Lewy bodies. Age and Ageing. 27: 631-6. PMID 12675102 DOI: 10.1093/Ageing/27.5.631  0.422
1998 McKeith IG, Ince P, Jaros EB, Fairbairn A, Ballard C, Grace J, Morris CM, Perry RH. What are the relations between Lewy body disease and AD? Journal of Neural Transmission. Supplementum. 54: 107-16. PMID 9850919 DOI: 10.1007/978-3-7091-7508-8_10  0.348
1998 Ince PG, Perry EK, Morris CM. Dementia with Lewy bodies. A distinct non-Alzheimer dementia syndrome? Brain Pathology (Zurich, Switzerland). 8: 299-324. PMID 9546289 DOI: 10.1111/J.1750-3639.1998.Tb00156.X  0.314
1997 Ballard C, McKeith I, Harrison R, O'Brien J, Thompson P, Lowery K, Perry R, Ince P. A detailed phenomenological comparison of complex visual hallucinations in dementia with Lewy bodies and Alzheimer's disease. International Psychogeriatrics / Ipa. 9: 381-8. PMID 9549588 DOI: 10.1017/S1041610297004523  0.408
1996 McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 47: 1113-24. PMID 8909416 DOI: 10.1212/Wnl.47.5.1113  0.366
1995 Strong C, Anderton BH, Perry RH, Perry EK, Ince PG, Lovestone S. Abnormally phosphorylated tau protein in senile dementia of Lewy body type and Alzheimer disease: evidence that the disorders are distinct. Alzheimer Disease and Associated Disorders. 9: 218-22. PMID 8749611 DOI: 10.1097/00002093-199500940-00008  0.316
1995 Court J, Perry E, Perry R, Ince P, Piggott M, Johnson M, Spurden D, Lloyd S. Changes in human brain nicotine receptors in dementia, development and aging: association with neuropathology and plasticity Pharmacological Research. 31: 172-172. DOI: 10.1016/1043-6618(95)86947-6  0.341
1993 Roberts GW, Nash M, Ince PG, Royston MC, Gentleman SM. On the origin of Alzheimer's disease: a hypothesis. Neuroreport. 4: 7-9. PMID 8453040 DOI: 10.1097/00001756-199301000-00001  0.375
1991 Ince P, Irving D, MacArthur F, Perry RH. Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients. Journal of the Neurological Sciences. 106: 142-52. PMID 1802962 DOI: 10.1016/0022-510X(91)90251-2  0.328
1991 Perry EK, McKeith I, Thompson P, Marshall E, Kerwin J, Jabeen S, Edwardson JA, Ince P, Blessed G, Irving D. Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease. Annals of the New York Academy of Sciences. 640: 197-202. PMID 1723256 DOI: 10.1111/J.1749-6632.1991.Tb00217.X  0.339
Show low-probability matches.